U.S. pharma big copyright scrapped two experimental weight loss capsules final yr—a the moment-everyday capsule, lotiglipron, resulting from elevated liver enzymes as well as a two times-day by day tablet, danuglipron, as a result of powerful side effects—but CEO Albert Bourla has me